GUARDION HEALTH SCIENCES INC (GHSI)
US40145Q5009 - Common Stock
Taking everything into account, GHSI scores 5 out of 10 in our fundamental rating. GHSI was compared to 36 industry peers in the Personal Care Products industry. While GHSI has a great health rating, there are worries on its profitability. GHSI is valied quite expensively at the moment, while it does show a decent growth rate.
1. Profitability
1.1 Basic Checks
GHSI had positive earnings in the past year.
In the past year GHSI has reported a negative cash flow from operations.
GHSI had negative earnings in 4 of the past 5 years.
In the past 5 years GHSI always reported negative operating cash flow.
1.2 Ratios
Looking at the Return On Assets, with a value of 41.65%, GHSI belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
GHSI's Return On Equity of 46.34% is amongst the best of the industry. GHSI outperforms 100.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 41.65% | ||
| ROE | 46.34% | ||
| ROIC | N/A |
ROA(3y)-59.1%
ROA(5y)-69.74%
ROE(3y)-76.49%
ROE(5y)-84.1%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
With an excellent Profit Margin value of 99.10%, GHSI belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
With a Gross Margin value of 44.84%, GHSI perfoms like the industry average, outperforming 41.67% of the companies in the same industry.
In the last couple of years the Gross Margin of GHSI has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | 99.1% | ||
| GM | 44.84% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y14.13%
GM growth 5Y-5.18%
2. Health
2.1 Basic Checks
GHSI does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, GHSI has more shares outstanding
GHSI has more shares outstanding than it did 5 years ago.
GHSI has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
Based on the Altman-Z score of -5.72, we must say that GHSI is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of GHSI (-5.72) is worse than 94.44% of its industry peers.
There is no outstanding debt for GHSI. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -5.72 |
ROIC/WACCN/A
WACC8.73%
2.3 Liquidity
A Current Ratio of 16.67 indicates that GHSI has no problem at all paying its short term obligations.
With an excellent Current ratio value of 16.67, GHSI belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
A Quick Ratio of 16.59 indicates that GHSI has no problem at all paying its short term obligations.
The Quick ratio of GHSI (16.59) is better than 100.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 16.67 | ||
| Quick Ratio | 16.59 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 154.16% over the past year.
Looking at the last year, GHSI shows a very negative growth in Revenue. The Revenue has decreased by -43.45% in the last year.
The Revenue has been growing by 67.11% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)154.16%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%963.44%
Revenue 1Y (TTM)-43.45%
Revenue growth 3Y86.44%
Revenue growth 5Y67.11%
Sales Q2Q%-97.39%
3.2 Future
Based on estimates for the next years, GHSI will show a very negative growth in Earnings Per Share. The EPS will decrease by -110.23% on average per year.
The Revenue is expected to grow by 9.78% on average over the next years. This is quite good.
EPS Next Y-669.3%
EPS Next 2Y-110.23%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year9.56%
Revenue Next 2Y9.78%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 7.56, which indicates a rather cheap valuation of GHSI.
Based on the Price/Earnings ratio, GHSI is valued cheaply inside the industry as 91.67% of the companies are valued more expensively.
Compared to an average S&P500 Price/Earnings ratio of 30.20, GHSI is valued rather cheaply.
GHSI is expected to report negative earnings next year, which makes the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 7.56 | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
GHSI's earnings are expected to decrease with -110.23% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-110.23%
EPS Next 3YN/A
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 153.85%, GHSI is a good candidate for dividend investing.
In the last 3 months the price of GHSI has falen by -67.14%. A price decline artificially increases the dividend yield. It may be a sign investors do not expect the dividend to last.
Compared to an average industry Dividend Yield of 4.29, GHSI pays a better dividend. On top of this GHSI pays more dividend than 100.00% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.26, GHSI pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 153.85% |
5.2 History
GHSI does not have a reliable dividend history as it only pays dividend since a couple or years.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
DPN/A
EPS Next 2Y-110.23%
EPS Next 3YN/A
GUARDION HEALTH SCIENCES INC
NASDAQ:GHSI (10/11/2024, 8:01:54 PM)
After market: 3.23 -0.02 (-0.62%)3.25
-0.01 (-0.31%)
Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap4.39M
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 153.85% |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 7.56 | ||
| Fwd PE | N/A | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 41.65% | ||
| ROE | 46.34% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | N/A | ||
| PM (TTM) | 99.1% | ||
| GM | 44.84% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.42
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 16.67 | ||
| Quick Ratio | 16.59 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)154.16%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y-669.3%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-43.45%
Revenue growth 3Y86.44%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y